A comprehensive overview of urogenital, anorectal and oropharyngeal Neisseria gonorrhoeae testing and diagnoses among different STI care providers: a cross-sectional study

Neisseria gonorrhoeae Medical microbiology Cross-sectional study
DOI: 10.1186/s12879-017-2402-0 Publication Date: 2017-04-20T04:35:32Z
ABSTRACT
Gonorrhoea, caused by Neisseria gonorrhoeae (NG), can cause reproductive morbidity, is increasingly becoming resistant to antibiotics and frequently asymptomatic, which shows the essential role of NG test practice. In this study we wanted compare diagnostic testing procedures between different STI care providers serving a defined geographic Dutch region (280,000 inhabitants).Data on laboratory diagnosis urogenital extragenital (i.e. anorectal oropharyngeal) were retrieved from general practitioners (GPs), an clinic, gynaecologists (2006-2010). Per provider, assessed their contribution regarding total number tests performed type populations tested, proportion positives re-tested (3-12 months after treatment) test-of-cure (TOC, within 3 post treatment).Overall, 17,702 (48.7% 38.2% GPs, 13.1% gynaecologists) during 15,458 patient visits. From tests, 2257 (12.7%) extragenital, 99.4% clinic. Men mostly tested at clinic (71%) women GP (43%). positivity per visit was 1.6%; 1.9% (n = 111), 1.7% 131) gynaecology 0.2% 5). associated with Chlamydia trachomatis (OR: 2.06, 95% confidence interval: 1.46-2.92). anatomical location, were: 20.3% 36), 43.6% 17) oropharyngeal 57.1% 20). among re-tests 16.9%. Proportions TOC location 10.2% 18), 17.9% 7) 17.1% 6).To achieve best practice in relation testing, recommend that: 1) GPs sites, especially men who have sex (MSM), 2) all consider re-testing 12 3) following settings provide services higher-risk (such as clinics).
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (22)
CITATIONS (17)